3M News Center

Community Program Helps Combat Adolescent Sexually Transmitted Disease Epidemic

- Nearly Half the New Cases of STDs Occur in Young Adults(1) -

Friday, April 16, 2004 7:00 am CDT

Dateline:

ST. PAUL, Minn.
"Recent estimates showing that nearly half of all new STD cases occur among the younger age group - 15 to 24 years of age - of America's sexually active population underscores the urgent need for increased STD awareness through education"

ST. PAUL, Minn.--(BUSINESS WIRE)--Nearly half of the 18.9 million new cases of sexually transmitted diseases (STD) occur in young adults 15 to 24 years of age each year in the United States, according to recent Centers for Disease Control (CDC) incidence and prevalence estimates.

"Recent estimates showing that nearly half of all new STD cases occur among the younger age group - 15 to 24 years of age - of America's sexually active population underscores the urgent need for increased STD awareness through education," said Dr. John Toney, medical director, Florida Sexually Transmitted Diseases - Human Immunodeficiency Virus Prevention Training Center, which is a part of the CDC National Network of STD/HIV Prevention Training Centers.

The most commonly acquired conditions are human papillomavirus (HPV), trichomoniasis and chlamydia(1). Genital HPV is the virus that causes external genital warts, and as many as 1 million new cases of external genital warts are diagnosed in the United States each year, according to the National Institute of Allergy and Infectious Diseases(2). Left untreated, genital warts can be more readily transmitted to sexual partners.

In response to a lack of HPV education and awareness, 3M Pharmaceuticals has designed the It Doesn't Discriminate program. This program was developed to enhance communication between health care providers and patients by addressing the signs, symptoms, causes and treatments of HPV and external genital warts. The It Doesn't Discriminate program will be presented at select national and regional nurse practitioner meetings throughout 2004.

Every nurse practitioner who participates in an It Doesn't Discriminate program receives an adaptable informational toolkit, which is used to educate their local communities about HPV and external genital warts. Health care providers who would like to present the program in their local communities can request the toolkit toll free at 877-856-6397 or IDD@KPRNY.com. It is important that consumers encourage their community centers and/or health clinics to incorporate this valuable program into their education agenda.

"The It Doesn't Discriminate program provides the framework for nurse practitioners to discuss these increasingly widespread conditions with their patients, so they can better care for their health," says Anne Moore, RNC, MSN, professor of nursing at Vanderbilt University, member of the American Academy of Nurse Practitioners (AANP), and board member of the National Association of Nurse Practitioners in Women's Health (NPWH).

There is no cure for the virus that causes external genital warts; however, treatment can eradicate external warts. Traditional treatments include surgical, laser or chemical techniques performed in the physician's office that involve tissue destruction. External genital warts can appear as small growths or bumps that may be raised or flat and can appear in a cluster with a cauliflower-like appearance.

About Patient-Applied Aldara (imiquimod) Cream, 5%

Aldara (imiquimod) cream, 5% is in a class of drugs referred to as immune response modifiers (IRM). Available by prescription only, Aldara cream is the only patient-applied cream approved by the FDA for the treatment of external genital and perianal warts. Aldara cream works by inducing the local production of specific cytokines which activate the body's immune system to clear the genital warts while reducing the level of HPV in the body. Patient-applied Aldara cream provides patients with a treatment choice that eliminates the need for chemical treatments or surgical removal of external genital warts.

In clinical trials most local skin reactions were mild to moderate and included erythema, erosion, flaking, edema, scabbing and induration at the wart site. Most common application-site reactions were itching (26 percent), burning (16 percent) and pain (4 percent) at the wart site. Application-site pigmentation changes have also been reported.

New warts may develop during treatment. The effect of Aldara Cream on the transmission of genital warts is unknown. Aldara Cream may weaken condoms and diaphragms. Sexual contact should be avoided while the cream is on the skin.

For more information about Aldara Cream, genital warts, or HPV, visit the 3M Pharmaceuticals web site at www.3m.com/aldara.

About 3M Pharmaceuticals - Part of the 3M Health Care Family

3M Health Care, the largest of seven major 3M businesses, is dedicated to improving the practice, delivery, and outcome of care in medical, dental, pharmaceutical, health information and personal care markets. 3M Pharmaceuticals, part of the 3M Health Care family, develops, manufactures and sells branded prescription drug products for dermatology, women's health, sexual health, cardiology and respiratory medicine. Additional information is available at www.3M.com/pharma.

About 3M -- A Global, Diversified Technology Company

Every day, 3M people find new ways to make amazing things happen. Wherever they are, whatever they do, the company's customers know they can rely on 3M to help make their lives better. 3M's brands include icons such as Scotch, Post-it, Scotchgard, Thinsulate, Scotch-Brite, Filtrete, Command and Dyneon. Serving customers in more than 200 countries around the world, the company's 67,000 people use their expertise, technologies and global strength to lead in major markets including consumer and office; display and graphics; electronics and telecommunications; safety, security and protection services; health care; industrial and transportation. For more information, including the latest product and technology news, visit www.3M.com.

Aldara, Scotch, Post-it, Scotchgard, Thinsulate, Scotch-Brite, Filtrete, Command and Dyneon are trademarks of 3M.

(1) Weinstock, H., Berman, S., Kates, Jr. W. (2000). Sexually Transmitted Diseases Among Youth: Incidence and Prevalence Estimates. Perspectives on Sexual and Reproductive Health, Vol. 36, 1, Jan/Feb 2004.

(2) Borucki, M. (1992). Overshadowed by AIDS, Other STDs Continue to Skyrocket. The DO, August 1992.

Contact:

KPR
Doug Esposito, 212-856-8472
or
3M Pharmaceuticals, St. Paul
John Cornwell, 651-733-7698

Related Materials

Follow Us
The brands listed above are trademarks of 3M.
Change Location
United States - English
Business Wire NewsHQsm